Group Mailing 2000-08-15

Priority Lists

Disease Committee	Last Changed
Breast Cancer	3/6/26
Cancer Care Delivery	8/4/25
comboMATCH	10/16/25
Early Therapeutics & Rare Cancers	11/7/25
Gastrointestinal Cancer	12/30/25
Genitourinary Cancer	1/19/26
Head and Neck Cancer	10/16/25
iMATCH	12/3/25
Immunomolecular Therapeutics	12/3/25
Leukemia	12/30/25
Lung Cancer	9/8/25
LungMAP	4/24/25
Lymphoma	10/23/25
Melanoma	11/7/25
Myeloma	10/23/25
myeloMATCH	12/30/25
Other	2/1/14
Palliative Care	10/24/25
Prevention, Screening, and Surveillance	1/1/25
Sarcoma	9/15/07
SWOG CTP	10/16/25
Symptom Management and Survivorship	10/24/25

S9716Phase II

A Phase II Trial of Cyclophosphamide, Methotrexate and 5-Fluorouracil (CMF) in Neuroendocrine Carcinoma of the Skin (Merkel Cell Carcinoma)

Study Coordinator(s)	Raymond A. Kempf, M.D., MPH, Ralph J. Tuthill, M.D.
Participants	Members, NCORP
Closure Date	2000-08-15

S9810Phase II

A Phase II Study of Gemcitabine and Cisplatin in Unresectable Malignant Mesothelioma

Study Coordinator(s)	Robert N. Taub, M.D.,Ph.D., Mary Louise Keohan, M.D.
Participants	Members, Medical Oncologists, NCORP
Closure Date	2000-08-15

A Phase II Trial of Complete Surgical Resection for Stage IV Melanoma-Surgical Resection with Biological and Clinical Follow-Up

Study Coordinator(s)	Jeffrey A. Sosman, M.D., Vernon K. Sondak, M.D., James A. Warneke, M.D., Cecilia M. Fenoglio-Preiser, M.D., Ralph J. Tuthill, M.D.
Participants	Members, NCORP, Medical Oncologists, Pathologists, Surgeons, ECOG